IKT · Inhibikase Therapeutics, Inc.
$2.41
+0.00 (+0.00%)
At close · Aug 14
Market Cap
$336.28M
Shares
139.54M
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
Equity Offering (ATM) Programs
| Program Established | Last Amended | Capacity | Remaining | Runs Through | Source |
|---|---|---|---|---|---|
| 2025-06-20 | — | $185,000,000 | — | — | 10-K , filed 2026-03-26 |
Key facts
CIK
1750149
CUSIP
45719W205
13F (30d)
106 filings
104 filers
Visit website
Investor relations